PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 204 filers reported holding PTC THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $821,000 | -28.2% | 16,364 | -32.2% | 0.00% | 0.0% |
Q1 2021 | $1,143,000 | -70.5% | 24,141 | -62.0% | 0.00% | -75.0% |
Q4 2020 | $3,875,000 | +30.5% | 63,500 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $2,969,000 | -4.1% | 63,500 | +4.1% | 0.00% | 0.0% |
Q2 2020 | $3,095,000 | +26.1% | 61,000 | +10.9% | 0.00% | 0.0% |
Q1 2020 | $2,454,000 | -7.1% | 55,000 | 0.0% | 0.00% | +33.3% |
Q4 2019 | $2,642,000 | +52.5% | 55,000 | +7.4% | 0.00% | +50.0% |
Q3 2019 | $1,732,000 | -16.2% | 51,200 | +11.5% | 0.00% | 0.0% |
Q2 2019 | $2,066,000 | +161.5% | 45,900 | +118.6% | 0.00% | +100.0% |
Q1 2019 | $790,000 | +54.9% | 21,000 | +33.5% | 0.00% | 0.0% |
Q4 2015 | $510,000 | -19.8% | 15,731 | +19.1% | 0.00% | 0.0% |
Q2 2015 | $636,000 | -51.9% | 13,213 | -39.2% | 0.00% | 0.0% |
Q1 2015 | $1,322,000 | -6.4% | 21,730 | -20.4% | 0.00% | 0.0% |
Q4 2014 | $1,413,000 | +53.8% | 27,300 | +30.6% | 0.00% | 0.0% |
Q3 2014 | $919,000 | – | 20,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
Chubb Ltd | 8,180 | $393,000 | 1.68% |